The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[(1R)-1-[(1-cyanocyclopropyl)carbamoyl]-2-[4-(pyridin-2-yl)piperazine-1-sulfonyl]ethyl]-3,3-dimethylbutanamide ID: ALA4777335
PubChem CID: 162643630
Max Phase: Preclinical
Molecular Formula: C22H32N6O4S
Molecular Weight: 476.60
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)CC(=O)N[C@@H](CS(=O)(=O)N1CCN(c2ccccn2)CC1)C(=O)NC1(C#N)CC1
Standard InChI: InChI=1S/C22H32N6O4S/c1-21(2,3)14-19(29)25-17(20(30)26-22(16-23)7-8-22)15-33(31,32)28-12-10-27(11-13-28)18-6-4-5-9-24-18/h4-6,9,17H,7-8,10-15H2,1-3H3,(H,25,29)(H,26,30)/t17-/m0/s1
Standard InChI Key: SJKOGFYCCHOYII-KRWDZBQOSA-N
Molfile:
RDKit 2D
33 35 0 0 0 0 0 0 0 0999 V2000
8.5888 -3.8548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3812 -4.0694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1708 -3.2759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0882 -8.4526 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6837 -7.7468 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.2747 -8.4500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6807 -5.2953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3880 -4.8877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9698 -4.8898 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6801 -6.1125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3910 -6.5221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3946 -7.3393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9526 -7.3861 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2724 -7.8390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5393 -7.4752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4863 -6.6586 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1688 -6.2091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8996 -6.5694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7567 -6.2925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0765 -6.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3457 -6.3851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2928 -5.5685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9730 -5.1155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7061 -5.4793 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0983 -6.1104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8051 -6.5159 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0947 -5.2932 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5124 -6.1042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0386 -6.7326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3184 -5.9600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2300 -5.3381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9476 -4.5721 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0903 -3.6588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
5 4 2 0
6 5 2 0
7 8 1 0
8 2 1 0
7 9 2 0
7 10 1 0
11 12 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
13 18 1 0
5 13 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
19 24 2 0
16 19 1 0
12 5 1 0
25 26 1 0
25 27 2 0
28 29 1 0
29 30 1 0
28 30 1 0
31 32 3 0
28 31 1 0
26 28 1 0
11 25 1 0
11 10 1 6
2 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 476.60Molecular Weight (Monoisotopic): 476.2206AlogP: 0.63#Rotatable Bonds: 8Polar Surface Area: 135.50Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.26CX Basic pKa: 6.42CX LogP: 0.27CX LogD: 0.23Aromatic Rings: 1Heavy Atoms: 33QED Weighted: 0.56Np Likeness Score: -1.76
References 1. Schade M,Merla B,Lesch B,Wagener M,Timmermanns S,Pletinckx K,Hertrampf T. (2020) Highly Selective Sub-Nanomolar Cathepsin S Inhibitors by Merging Fragment Binders with Nitrile Inhibitors., 63 (20.0): [PMID:32880457 ] [10.1021/acs.jmedchem.0c00949 ] 2. de Esch IJP, Erlanson DA, Jahnke W, Johnson CN, Walsh L.. (2022) Fragment-to-Lead Medicinal Chemistry Publications in 2020., 65 (1.0): [PMID:34928151 ] [10.1021/acs.jmedchem.1c01803 ]